Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients

被引:69
|
作者
Toussaint, Nigel D. [1 ,2 ]
Polkinghorne, Kevan R. [1 ,2 ]
Kerr, Peter G. [1 ,2 ]
机构
[1] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Med, Clayton, Vic, Australia
关键词
arterial compliance; B-type natriuretic peptide; cardiovascular disease; exercise; hemodialysis; pulse wave velocity;
D O I
10.1111/j.1542-4758.2008.00262.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular (CV) disease is the most common cause of mortality in end-stage kidney disease (ESKD), and arterial stiffness, measured by pulse wave velocity (PWV), is an independent predictor of all-cause and CV mortality. B-type natriuretic peptide (BNP) levels are high in patients with CV disease and ESKD, and increases in BNP may also be a marker of CV risk. Regular exercise has many benefits on quality of life and physical strength and may also improve CV risk, but few studies have addressed the impact of exercise on CV risk in ESKD. We performed a prospective cross-over trial in 19 hemodialysis (HD) patients to assess the impact of regular exercise on surrogate markers of CV risk-arterial compliance and BNP levels. Exercise involved the use of a bicycle ergometer for minimum 30 min at each HD session for 3 months, with a 1-month washout period. Group A (n=9) exercised for the first 3 months only, while group B (n= 10) performed no intradialytic exercise initially and exercised for 3 months at cross-over (month 4). Pulse wave velocity was performed using a SphygmoCor device, with concurrent measurements of BNP and other serum markers, at the commencement of the study, at 3 months, and on completion. The mean PWV (A: 10.4 +/- 3.1 m/s, B: 9.8 +/- 3.8 at baseline) showed a trend toward improvement with exercise (A: 8.7 +/- 2.7, p=0.07), and no significant change without (B: 10.5 +/- 3.6, p=0.3 1). After cross-over, there was an increase in PWV in group A with cessation of exercise (9.75 +/- 2.4, p=0.01 vs. 3 months) and an improvement in group B with exercise (9.33 +/- 2.3, p=0.11 vs. 3 months). When comparing PWV after 3 months of exercise vs. 3 months of no exercise (paired t test), there was a significant difference in favor of exercise (9.04 +/- 0.59 vs. 10.16 +/- 0.74, p=0.008). The mean BNP levels following 3 months of exercise were also lower than those after 3 months of no exercise (504.4 +/- 101.2 vs. 809.4 +/- 196.1 [N <100], p=0.047). There was an overall improvement in PWV, and to a lesser extent BNP levels, with 3 months of intradialytic exercise compared with no exercise, suggesting that regular exercise in ESKD may be associated with improvements in arterial compliance and a reduction in CV risk.
引用
收藏
页码:254 / 263
页数:10
相关论文
共 50 条
  • [1] B-type (brain) natriuretic peptide and pruritus in hemodialysis patients
    Shimizu, Yoshio
    Sonoda, Ayano
    Nogi, Chieko
    Ogushi, Yoko
    Kanda, Reo
    Yamaguchi, Saori
    Nohara, Nao
    Aoki, Tatsuya
    Yamada, Kaori
    Nakata, Junichiro
    Io, Hiroaki
    Kurusu, Atsushi
    Hamada, Chieko
    Horikoshi, Satoshi
    Tomino, Yasuhiko
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2014, 7 : 329 - 335
  • [2] Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptide
    McNairy, M
    Gardetto, N
    Clopton, P
    Garcia, A
    Krishnaswamy, P
    Kazanegra, R
    Ziegler, M
    Maisel, AS
    AMERICAN HEART JOURNAL, 2002, 143 (03) : 406 - 411
  • [3] Effect of Obesity on B-Type Natriuretic Peptide Levels in Patients With Pulmonary Arterial Hypertension
    Batal, Omar
    Faulx, Michael
    Krasuski, Richard A.
    Khatib, Omar F.
    Hammel, Jeff P.
    Hussein, Ayman A.
    Minai, Omar A.
    Dweik, Raed A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (06): : 909 - 914
  • [4] CLINICAL SIGNIFICANCE OF B-TYPE NATRIURETIC PEPTIDE LEVELS AND IMPEDANCE CARDIOGRAPHY IN MAINTENANCE HEMODIALYSIS PATIENTS
    Han, Byoung Geun
    Choi, Seung Ok
    NEPHROLOGY, 2005, 10 : A293 - A293
  • [5] B-type natriuretic peptide levels and volume status in twice-weekly hemodialysis patients
    Fang, Nina
    Che, Miaolin
    Shi, Ling
    Yu, Zanzhe
    Ni, Zhaohui
    Fang, Wei
    Pang, Huihua
    Gu, Leyi
    Lin, Xinghui
    RENAL FAILURE, 2021, 43 (01) : 1259 - 1265
  • [6] Prognostic potential of B-type natriuretic peptide in unselected hemodialysis patients
    Kalbermatter, S.
    Breidthardt, T.
    Lingenhel, S.
    Mueller, C.
    Kiss, D.
    SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 19S - 19S
  • [7] B-type natriuretic peptide is not a volume marker among patients on hemodialysis
    Agarwal, Rajiv
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (12) : 3082 - 3089
  • [8] Differences of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide levels in patients with cardiogenic shock
    Buerke, Michael
    Prondzinsky, Roland
    Geppert, Alexander
    Jaral, Rudolf
    Huber, Kurt
    Russ, Martin
    Lemm, Henning
    Schlitt, Axel
    Werdan, Karl
    CIRCULATION, 2007, 116 (16) : 944 - 944
  • [9] Olmesartan Medoxomil Treatment Is Associated with Decreased Plasma B-Type Natriuretic Peptide Levels in Patients on Hemodialysis
    Suzuki, Ryuji
    Honda, Hirokazu
    Niikura, Kazuhiko
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2012, 34 (02) : 125 - 131
  • [10] B-type natriuretic peptide: A novel cardiovascular prognostic marker in hemodialysis patients
    Yilmaz, R
    Altun, B
    Arici, M
    Sahiner, L
    Erdem, Y
    Yasavul, U
    Turgan, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V26 - V26